Regeneus Ltd (ASX: RGS) merged with Cambium Medical Technologies creating Cambium Bio Limited (ASX:CMB), focusing on dry eye and ophthalmology. For more information about the Company and its programs, please visit www.cambium.bio
Biotechnology Research, Pharmaceutical veterinary preparations, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Scientific Research and Development Services, Services